Trial Profile
Adalimumab (Humira) in the Treatment of Chronic Pouchitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Pouchitis
- Focus Therapeutic Use
- 27 Jan 2016 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 25 Apr 2015 New trial record